Intuitive Surgical vs Stryker

Intuitive Surgical and Stryker are two leading companies in the medical technology industry, both known for their innovative products in the field of robotic surgery. Intuitive Surgical's flagship product, the da Vinci Surgical System, has revolutionized minimally invasive surgeries, while Stryker's Mako Surgical System has gained popularity for its precision in orthopedic procedures. Investors have been closely monitoring the performance of these two stocks, as both companies continue to expand their market presence and seek growth opportunities in the healthcare sector.

Intuitive Surgical or Stryker?

When comparing Intuitive Surgical and Stryker, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Intuitive Surgical and Stryker.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Intuitive Surgical has a dividend yield of -%, while Stryker has a dividend yield of 0.89%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Intuitive Surgical reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Stryker reports a 5-year dividend growth of 9.58% year and a payout ratio of 34.19%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Intuitive Surgical P/E ratio at 81.13 and Stryker's P/E ratio at 39.67. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Intuitive Surgical P/B ratio is 11.55 while Stryker's P/B ratio is 6.92.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Intuitive Surgical has seen a 5-year revenue growth of 0.86%, while Stryker's is 0.49%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Intuitive Surgical's ROE at 15.36% and Stryker's ROE at 18.28%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $476.68 for Intuitive Surgical and $357.09 for Stryker. Over the past year, Intuitive Surgical's prices ranged from $254.85 to $496.48, with a yearly change of 94.81%. Stryker's prices fluctuated between $255.22 and $374.63, with a yearly change of 46.79%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.